Evidence supporting the use of: Fish oil
For the health condition: Arrhythmia

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 3

Fish oil, rich in omega-3 fatty acids (primarily EPA and DHA), has been studied for its potential role in the management and prevention of arrhythmias. The scientific rationale is rooted in the observation that populations with high dietary intake of omega-3 fatty acids tend to have lower rates of sudden cardiac death, a significant proportion of which is due to ventricular arrhythmias. Mechanistically, omega-3 fatty acids may stabilize cardiac cell membranes and modulate ion channels, resulting in anti-arrhythmic effects.

Several clinical studies and meta-analyses have investigated fish oil supplementation in arrhythmia. Early trials, such as the GISSI-Prevenzione study, suggested a reduction in sudden cardiac death in post-myocardial infarction patients taking fish oil. However, more recent randomized controlled trials (RCTs) have yielded mixed results, with some failing to show significant reduction in arrhythmia incidence or recurrence, particularly in patients with established heart failure or those with implantable cardioverter-defibrillators (ICDs).

Current guidelines from major cardiology societies do not universally recommend routine fish oil supplementation for arrhythmia prevention or treatment, but acknowledge that it may be reasonable in certain high-risk populations. Overall, while there is a plausible scientific basis and some supportive clinical data, the evidence is moderate and not conclusive, leading to a rating of 3/5 for scientific support.

More about fish oil
More about Arrhythmia